𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Once-daily propranolol extended-release tablet dosage form: formulation design and in vitro/in vivo investigation

✍ Scribed by Yaw-Bin Huang; Yi-Hung Tsai; Wan-Chiech Yang; Jui-Sheng Chang; Pao-Chu Wu; Kozo Takayama

Book ID
116437265
Publisher
Elsevier Science
Year
2004
Tongue
French
Weight
269 KB
Volume
58
Category
Article
ISSN
0939-6411

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Once-a-day controlled-release dosage for
Once-a-day controlled-release dosage form of divalproex sodium I: Formulation design and in vitro/in vivo investigations
✍ Yihong Qiu; Howard S. Cheskin; Kevin R. Engh; Richard P. Poska πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 237 KB πŸ‘ 1 views

Divalproex sodium is a narrow therapeutic index drug that is widely used for the treatment of epilepsy, the manic episodes associated with bipolar disorder, and prophylaxis of migraine headaches. The present investigation was undertaken to design an oral dosage form that would provide once-daily adm

Once-a-day extended-release dosage form
Once-a-day extended-release dosage form of divalproex sodium III: Development and validation of a Level A in vitro–in vivo correlation (IVIVC)
✍ Sandeep Dutta; Yihong Qiu; Emil Samara; Guoliang Cao; G. Richard Granneman πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 257 KB πŸ‘ 1 views

Defining a quantitative and reliable relationship between in vitro drug release and in vivo absorption is highly desired for rational development, optimization, and evaluation of controlled-release dosage forms and manufacturing process. During the development of a once-daily extended-release (ER) t